Esteban, I.; Pastor-Quiñones, C.; Usero, L.; Aurrecoechea, E.; Franceschini, L.; Esprit, A.; GelpÃ, J.L.; MartÃnez-Jiménez, F.; López-Bigas, N.; Breckpot, K.;
et al. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA). Vaccines 2024, 12, 15.
https://doi.org/10.3390/vaccines12010015
AMA Style
Esteban I, Pastor-Quiñones C, Usero L, Aurrecoechea E, Franceschini L, Esprit A, Gelpà JL, MartÃnez-Jiménez F, López-Bigas N, Breckpot K,
et al. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA). Vaccines. 2024; 12(1):15.
https://doi.org/10.3390/vaccines12010015
Chicago/Turabian Style
Esteban, Ignasi, Carmen Pastor-Quiñones, Lorena Usero, Elena Aurrecoechea, Lorenzo Franceschini, Arthur Esprit, Josep LluÃs GelpÃ, Francisco MartÃnez-Jiménez, Núria López-Bigas, Karine Breckpot,
and et al. 2024. "Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)" Vaccines 12, no. 1: 15.
https://doi.org/10.3390/vaccines12010015
APA Style
Esteban, I., Pastor-Quiñones, C., Usero, L., Aurrecoechea, E., Franceschini, L., Esprit, A., GelpÃ, J. L., MartÃnez-Jiménez, F., López-Bigas, N., Breckpot, K., Thielemans, K., Leal, L., Gómez, C. E., Sisteré-Oró, M., Meyerhans, A., Esteban, M., Alonso, M. J., GarcÃa, F., & Plana, M., on behalf of the COVARNA Consortium.
(2024). Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA). Vaccines, 12(1), 15.
https://doi.org/10.3390/vaccines12010015
